The state of Indiana and the city of Bloomington announced Monday that Somerset, New Jersey-based Catalent Inc. plans a "significant expansion" of its manufacturing of biologics.

After eight years of development, the Indiana Hemophilia and Thrombosis Center took part in a clinical trial that lead to the FDA approving the new treatment for patients with hemophilia A.

Endocyte was founded in Purdue Research Park and has been working for more than two decades to develop personalized cancer treatments.

Nichole Smith-Holt lost her 26-years-old son, Alec, last year when he began rationing insulin, unable to afford each month's supply. Since his death, she has made it a mission to address insulin insecurity.

The price of the insulin more than doubled from 2002 to 2013.

Eli Lilly and Pfizer are working together to develop the new class of drug that is in late-trial stages. There hasn't been a new pain medication discovery in about 50 years. The last new non-opioid pain medication to hit the market was ibuprofen in the late 1960s.

An investigation by NPR and WFYI's public health news service, Side Effects Public Media, found that in statehouses across the country, and in Congress, drugmaker Alkermes is pushing its addiction treatment drug, Vivitrol, while contributing to misconceptions and stigma about other medications used to treat opioid addiction.

The Indiana attorney general's office says the settlement resolves allegations of unlawful, anticompetitive conduct involving the drug Provigil,

The news of layoffs follows last month's announcement concerning the failure of Solanezumab, which Lilly hoped would be the first drug to slow the progression of Alzheimer's Disease.

The drugmaker announced Monday that the new building will feature a multi-disciplinary laboratory where organic chemists and engineers will work alongside other scientists in multiple research areas.